Literature DB >> 12569191

Common sense and common consent in communicable disease surveillance.

L Turnberg1.   

Abstract

The need to protect the public against the spread of communicable (infectious) disease provides a good example of the need for a commonsense approach to the use of confidential data. Laboratories need to notify different professionals in order to trace the sources of outbreaks of infection and eradicate the cause. It is often not possible to obtain consent from individual patients, given the rapid time scale required. In doing so, however, laboratory staff and others would contravene the Data Protection Act in passing on information without consent. Section 60 of the Health and Social Care Act was designed to overcome barriers to research relying on data accumulated in the past and this type of public health work. But this is proving a sluggish procedure. It is an awkward solution to the problem of data use without specific consent. This problem will be overcome only when the public can have sufficient trust in safeguards that are in place to protect their safety and confidentiality so that these important activities can be pursued without specific informed consent.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2003        PMID: 12569191      PMCID: PMC1733677          DOI: 10.1136/jme.29.1.27

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Legal and ethical considerations in processing patient-identifiable data without patient consent: lessons learnt from developing a disease register.

Authors:  Charlotte L Haynes; Gary A Cook; Michael A Jones
Journal:  J Med Ethics       Date:  2007-05       Impact factor: 2.903

Review 2.  Professional-patient relationships and informed consent.

Authors:  N G Messer
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

3.  Public attitudes towards the use of primary care patient record data in medical research without consent: a qualitative study.

Authors:  M R Robling; K Hood; H Houston; R Pill; J Fay; H M Evans
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.